About Precision Therapeutics
Precision Therapeutics, a leading life-science company based in Pittsburgh, Pennsylvania, is dedicated to utilizing precision medicine for personalized cancer care. Precision offers a portfolio of products developed to help guide physicians and patients with difficult clinical decisions throughout the cancer care continuum: - The ChemoFx® Drug Response Assay can identify platinum-resistant/refractory primary ovarian patients. Studies have also shown a 14 month (65%) improvement in overall survival (OS) and improved progression free survival (PFS) when recurrent ovarian cancer patients are treated with responsive therapies as indicated by ChemoFx. Precision Therapeutics currently receives ChemoFx specimens from 271 top medical institutions including 20 of the 21 National Comprehensive Cancer Network (NCCN) Member Institutions, and 8 of the US News and World Report Top 10 Hospitals for Cancer Care. Over 25,000 Gynecologic specimens have been submitted for ChemoFx testing since 2012 from
Precision Therapeutics Job Openings
Create job profile to receive interview calls for your dream job
Create Job Alert Kick Start! your career with best matching jobs
Location
X